Dextroamphetamine Sulfate
Dextroamphetamine Sulfate Tablets, USP CII Rx only
9acdf000-fefe-47c7-a44c-0f7a65c5c05c
HUMAN PRESCRIPTION DRUG LABEL
Oct 23, 2023
Tris Pharma Inc
DUNS: 947472119
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dextroamphetamine Sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
Dextroamphetamine Sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
Drug Labeling Information
DRUG ABUSE AND DEPENDENCE SECTION
DRUG ABUSE AND DEPENDENCE
Controlled Substance
Dextroamphetamine sulfate is a Schedule II controlled substance.
Abuse
Dextroamphetamine sulfate has a high potential for abuse and misuse which can
lead to the development of a substance use disorder, including addiction (see
WARNINGS).
Dextroamphetamine sulfate can be diverted for non-medical use into illicit
channels or distribution.
Abuse is the intentional non-therapeutic use of a drug, even once, to achieve a desired psychological or physiological effect. Misuse is the intentional use, for therapeutic purposes, of a drug by an individual in a way other than prescribed by a health care provider or for whom it was not prescribed. Drug addiction is a cluster of behavioral, cognitive, and physiological phenomena that may include a strong desire to take the drug, difficulties in controlling drug use (e.g., continuing drug use despite harmful consequences, giving a higher priority to drug use than other activities and obligations), and possible tolerance or physical dependence.
Misuse and abuse of amphetamines may cause increased heart rate, respiratory rate, or blood pressure; sweating; dilated pupils; hyperactivity; restlessness; insomnia; decreased appetite; loss of coordination; tremors; flushed skin; vomiting; and/or abdominal pain. Anxiety, psychosis, hostility, aggression, and suicidal or homicidal ideation have also been observed with CNS stimulants abuse and/or misuse. Misuse and abuse of CNS stimulants, including dextroamphetamine sulfate, can result in overdose and death (see OVERDOSAGE), and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Dependence
Physical Dependence
Dextroamphetamine sulfate may produce physical dependence. Physical dependence
is a state that develops as a result of physiological adaptation in response
to repeated drug use, manifested by withdrawal signs and symptoms after abrupt
discontinuation or a significant dose reduction of a drug.
Withdrawal signs and symptoms after abrupt discontinuation or dose reduction following prolonged use of CNS stimulants including dextroamphetamine sulfate include dysphoric mood; depression; fatigue; vivid, unpleasant dreams; insomnia or hypersomnia; increased appetite; and psychomotor retardation or agitation.
Tolerance
Dextroamphetamine sulfate may produce tolerance. Tolerance is a physiological
state characterized by a reduced response to a drug after repeated
administration (i.e., a higher dose of a drug is required to produce the same
effect that was once obtained at a lower dose).